Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of Americaa.

Nicolle LE, Gupta K, Bradley SF, Colgan R, DeMuri GP, Drekonja D, Eckert LO, Geerlings SE, Köves B, Hooton TM, Juthani-Mehta M, Knight SL, Saint S, Schaeffer AJ, Trautner B, Wullt B, Siemieniuk R.

Clin Infect Dis. 2019 May 2;68(10):1611-1615. doi: 10.1093/cid/ciz021.

PMID:
31506700
2.

Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of Americaa.

Nicolle LE, Gupta K, Bradley SF, Colgan R, DeMuri GP, Drekonja D, Eckert LO, Geerlings SE, Köves B, Hooton TM, Juthani-Mehta M, Knight SL, Saint S, Schaeffer AJ, Trautner B, Wullt B, Siemieniuk R.

Clin Infect Dis. 2019 May 2;68(10):e83-e110. doi: 10.1093/cid/ciy1121.

PMID:
30895288
3.

Association between urinary community-acquired fluoroquinolone-resistant Escherichia coli and neighbourhood antibiotic consumption: a population-based case-control study.

Low M, Neuberger A, Hooton TM, Green MS, Raz R, Balicer RD, Almog R.

Lancet Infect Dis. 2019 Apr;19(4):419-428. doi: 10.1016/S1473-3099(18)30676-5. Epub 2019 Mar 4.

PMID:
30846277
4.

Delivery of Bottled Water to Women With Recurrent Urinary Tract Infections: Why in Bulgaria?-Reply.

Hooton TM, Vecchio M, Lotan Y.

JAMA Intern Med. 2019 Mar 1;179(3):449. doi: 10.1001/jamainternmed.2018.7977. No abstract available.

PMID:
30830193
5.

Effect of Increased Daily Water Intake in Premenopausal Women With Recurrent Urinary Tract Infections: A Randomized Clinical Trial.

Hooton TM, Vecchio M, Iroz A, Tack I, Dornic Q, Seksek I, Lotan Y.

JAMA Intern Med. 2018 Nov 1;178(11):1509-1515. doi: 10.1001/jamainternmed.2018.4204.

6.

Practices of clinical microbiology laboratories in reporting voided urine culture results.

Sfeir MM, Hooton TM.

Clin Microbiol Infect. 2018 Jun;24(6):669-670. doi: 10.1016/j.cmi.2017.12.023. Epub 2018 Jan 6. No abstract available.

7.

A Case-Crossover Study of Urological Chronic Pelvic Pain Syndrome Flare Triggers in the MAPP Research Network.

Sutcliffe S, Jemielita T, Lai HH, Andriole GL, Bradley CS, Clemens JQ, Gallop R, Hooton TM, Kreder KJ, Krieger JN, Kusek JW, Labus J, Lucia MS, Mackey S, Naliboff BD, Robinson NA, Rodriguez LV, Stephens-Shields A, van Bokhoven A, Wolin KY, Yan Y, Yang CC, Landis JR, Colditz GA; MAPP Research Network.

J Urol. 2018 May;199(5):1245-1251. doi: 10.1016/j.juro.2017.12.050. Epub 2017 Dec 27.

8.

Bacterial virulence phenotypes of Escherichia coli and host susceptibility determine risk for urinary tract infections.

Schreiber HL 4th, Conover MS, Chou WC, Hibbing ME, Manson AL, Dodson KW, Hannan TJ, Roberts PL, Stapleton AE, Hooton TM, Livny J, Earl AM, Hultgren SJ.

Sci Transl Med. 2017 Mar 22;9(382). pii: eaaf1283. doi: 10.1126/scitranslmed.aaf1283.

9.

Diagnosis, Treatment, and Prevention of Urinary Tract Infection.

Pietrucha-Dilanchian P, Hooton TM.

Microbiol Spectr. 2016 Dec;4(6). doi: 10.1128/microbiolspec.UTI-0021-2015. Review.

PMID:
28087935
10.

Urinary Metabolomics Identifies a Molecular Correlate of Interstitial Cystitis/Bladder Pain Syndrome in a Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Cohort.

Parker KS, Crowley JR, Stephens-Shields AJ, van Bokhoven A, Lucia MS, Lai HH, Andriole GL, Hooton TM, Mullins C, Henderson JP.

EBioMedicine. 2016 May;7:167-74. doi: 10.1016/j.ebiom.2016.03.040. Epub 2016 Mar 31.

11.

Inhibition of Cyclooxygenase-2 Prevents Chronic and Recurrent Cystitis.

Hannan TJ, Roberts PL, Riehl TE, van der Post S, Binkley JM, Schwartz DJ, Miyoshi H, Mack M, Schwendener RA, Hooton TM, Stappenbeck TS, Hansson GC, Stenson WF, Colonna M, Stapleton AE, Hultgren SJ.

EBioMedicine. 2014 Oct 24;1(1):46-57. doi: 10.1016/j.ebiom.2014.10.011. eCollection 2014 Nov.

12.

Performance of a New Rapid Immunoassay Test Kit for Point-of-Care Diagnosis of Significant Bacteriuria.

Stapleton AE, Cox ME, DiNello RK, Geisberg M, Abbott A, Roberts PL, Hooton TM.

J Clin Microbiol. 2015 Sep;53(9):2805-9. doi: 10.1128/JCM.00353-15. Epub 2015 Jun 10.

13.

Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection.

Steigedal M, Marstad A, Haug M, Damås JK, Strong RK, Roberts PL, Himpsl SD, Stapleton A, Hooton TM, Mobley HL, Hawn TR, Flo TH.

J Immunol. 2014 Dec 15;193(12):6081-9. doi: 10.4049/jimmunol.1401528. Epub 2014 Nov 14.

14.

Free antibiotic and vaccination programmes in community pharmacies of Miami-Dade County, FL, USA.

Gauthier TP, Suda KJ, Mathur SK, Harriman D, Pham J, Aragon L, Abbo LM, Hooton TM.

J Antimicrob Chemother. 2015 Feb;70(2):594-7. doi: 10.1093/jac/dku417. Epub 2014 Oct 19.

PMID:
25331056
15.

Human papillomavirus awareness among HIV-infected drug users in two urban areas.

Rosa-Cunha I, Hooton TM, Cardenas GA, Del Rio C, Bonney LE, Pereyra M, Metsch LR.

Int J STD AIDS. 2014 Dec;25(14):992-6. doi: 10.1177/0956462414527070. Epub 2014 Mar 10.

PMID:
24616115
16.

Antimicrobial Stewardship and Urinary Tract Infections.

Abbo LM, Hooton TM.

Antibiotics (Basel). 2014 May 5;3(2):174-92. doi: 10.3390/antibiotics3020174. Review.

17.

Voided midstream urine culture and acute cystitis in premenopausal women.

Hooton TM, Roberts PL, Cox ME, Stapleton AE.

N Engl J Med. 2013 Nov 14;369(20):1883-91. doi: 10.1056/NEJMoa1302186.

18.

Management of antimicrobial allergies by infectious diseases physicians.

Abbo LM, Beekmann SE, Hooton TM, Johannsson B, Polgreen PM.

JAMA Intern Med. 2013 Jul 22;173(14):1376-8. doi: 10.1001/jamainternmed.2013.6480. No abstract available.

PMID:
23877081
19.

From physiology to pharmacy: developments in the pathogenesis and treatment of recurrent urinary tract infections.

Silverman JA, Schreiber HL 4th, Hooton TM, Hultgren SJ.

Curr Urol Rep. 2013 Oct;14(5):448-56. doi: 10.1007/s11934-013-0354-5. Review.

20.

Estrogen and recurrent UTI: what are the facts?

Hannan TJ, Hooton TM, Hultgren SJ.

Sci Transl Med. 2013 Jun 19;5(190):190fs23. doi: 10.1126/scitranslmed.3006423.

PMID:
23785033
21.

The type 1 pili regulator gene fimX and pathogenicity island PAI-X as molecular markers of uropathogenic Escherichia coli.

Bateman SL, Stapleton AE, Stamm WE, Hooton TM, Seed PC.

Microbiology. 2013 Aug;159(Pt 8):1606-17. doi: 10.1099/mic.0.066472-0. Epub 2013 Jun 6.

22.

Medical students' perceptions and knowledge about antimicrobial stewardship: how are we educating our future prescribers?

Abbo LM, Cosgrove SE, Pottinger PS, Pereyra M, Sinkowitz-Cochran R, Srinivasan A, Webb DJ, Hooton TM.

Clin Infect Dis. 2013 Sep;57(5):631-8. doi: 10.1093/cid/cit370. Epub 2013 May 31.

PMID:
23728148
23.

Genomic diversity and fitness of E. coli strains recovered from the intestinal and urinary tracts of women with recurrent urinary tract infection.

Chen SL, Wu M, Henderson JP, Hooton TM, Hibbing ME, Hultgren SJ, Gordon JI.

Sci Transl Med. 2013 May 8;5(184):184ra60. doi: 10.1126/scitranslmed.3005497.

24.

Antimicrobial stewardship programs in Florida's acute care facilities.

Abbo L, Lo K, Sinkowitz-Cochran R, Burke AC, Hopkins RS, Srinivasan A, Hooton TM.

Infect Control Hosp Epidemiol. 2013 Jun;34(6):634-7. doi: 10.1086/670632. Epub 2013 Apr 16.

PMID:
23651897
25.

Escherichia coli isolates that carry vat, fyuA, chuA, and yfcV efficiently colonize the urinary tract.

Spurbeck RR, Dinh PC Jr, Walk ST, Stapleton AE, Hooton TM, Nolan LK, Kim KS, Johnson JR, Mobley HL.

Infect Immun. 2012 Dec;80(12):4115-22. doi: 10.1128/IAI.00752-12. Epub 2012 Sep 10.

26.

Clinical practice. Uncomplicated urinary tract infection.

Hooton TM.

N Engl J Med. 2012 Mar 15;366(11):1028-37. doi: 10.1056/NEJMcp1104429. Review. No abstract available.

PMID:
22417256
27.

Cefpodoxime vs ciprofloxacin for short-course treatment of acute uncomplicated cystitis: a randomized trial.

Hooton TM, Roberts PL, Stapleton AE.

JAMA. 2012 Feb 8;307(6):583-9. doi: 10.1001/jama.2012.80.

28.

Recurrent urinary tract infection and urinary Escherichia coli in women ingesting cranberry juice daily: a randomized controlled trial.

Stapleton AE, Dziura J, Hooton TM, Cox ME, Yarova-Yarovaya Y, Chen S, Gupta K.

Mayo Clin Proc. 2012 Feb;87(2):143-50. doi: 10.1016/j.mayocp.2011.10.006.

29.

Antimicrobial prophylaxis in women with recurrent urinary tract infections.

Lichtenberger P, Hooton TM.

Int J Antimicrob Agents. 2011 Dec;38 Suppl:36-41. doi: 10.1016/j.ijantimicag.2011.09.005. Epub 2011 Nov 4. Review.

PMID:
22055655
30.

Managing uncomplicated urinary tract infection--making sense out of resistance data.

Gupta K, Hooton TM, Miller L; Uncomplicated UTI IDSA Guideline Committee.

Clin Infect Dis. 2011 Nov;53(10):1041-2. doi: 10.1093/cid/cir637. Epub 2011 Sep 22. No abstract available.

PMID:
21940416
31.

Development of an integrated metabolomic profiling approach for infectious diseases research.

Lv H, Hung CS, Chaturvedi KS, Hooton TM, Henderson JP.

Analyst. 2011 Nov 21;136(22):4752-63. doi: 10.1039/c1an15590c. Epub 2011 Sep 16.

32.

Fimbrial profiles predict virulence of uropathogenic Escherichia coli strains: contribution of ygi and yad fimbriae.

Spurbeck RR, Stapleton AE, Johnson JR, Walk ST, Hooton TM, Mobley HL.

Infect Immun. 2011 Dec;79(12):4753-63. doi: 10.1128/IAI.05621-11. Epub 2011 Sep 12.

33.

Faculty and resident physicians' attitudes, perceptions, and knowledge about antimicrobial use and resistance.

Abbo L, Sinkowitz-Cochran R, Smith L, Ariza-Heredia E, Gómez-Marín O, Srinivasan A, Hooton TM.

Infect Control Hosp Epidemiol. 2011 Jul;32(7):714-8. doi: 10.1086/660761.

PMID:
21666405
34.

Presence of putative repeat-in-toxin gene tosA in Escherichia coli predicts successful colonization of the urinary tract.

Vigil PD, Stapleton AE, Johnson JR, Hooton TM, Hodges AP, He Y, Mobley HL.

MBio. 2011 May 3;2(3):e00066-11. doi: 10.1128/mBio.00066-11. Print 2011.

35.

Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection.

Stapleton AE, Au-Yeung M, Hooton TM, Fredricks DN, Roberts PL, Czaja CA, Yarova-Yarovaya Y, Fiedler T, Cox M, Stamm WE.

Clin Infect Dis. 2011 May;52(10):1212-7. doi: 10.1093/cid/cir183. Epub 2011 Apr 14.

36.

International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.

Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE; Infectious Diseases Society of America; European Society for Microbiology and Infectious Diseases.

Clin Infect Dis. 2011 Mar 1;52(5):e103-20. doi: 10.1093/cid/ciq257. Review.

PMID:
21292654
37.

Family history and risk of recurrent cystitis and pyelonephritis in women.

Scholes D, Hawn TR, Roberts PL, Li SS, Stapleton AE, Zhao LP, Stamm WE, Hooton TM.

J Urol. 2010 Aug;184(2):564-9. doi: 10.1016/j.juro.2010.03.139. Epub 2010 Jun 19.

38.

Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America.

Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, Saint S, Schaeffer AJ, Tambayh PA, Tenke P, Nicolle LE; Infectious Diseases Society of America.

Clin Infect Dis. 2010 Mar 1;50(5):625-63.

PMID:
20175247
39.

Genetic variation of the human urinary tract innate immune response and asymptomatic bacteriuria in women.

Hawn TR, Scholes D, Wang H, Li SS, Stapleton AE, Janer M, Aderem A, Stamm WE, Zhao LP, Hooton TM.

PLoS One. 2009 Dec 15;4(12):e8300. doi: 10.1371/journal.pone.0008300.

40.

Peer support and pager messaging to promote antiretroviral modifying therapy in Seattle: a randomized controlled trial.

Simoni JM, Huh D, Frick PA, Pearson CR, Andrasik MP, Dunbar PJ, Hooton TM.

J Acquir Immune Defic Syndr. 2009 Dec 1;52(4):465-473.

41.

Prospective cohort study of microbial and inflammatory events immediately preceding Escherichia coli recurrent urinary tract infection in women.

Czaja CA, Stamm WE, Stapleton AE, Roberts PL, Hawn TR, Scholes D, Samadpour M, Hultgren SJ, Hooton TM.

J Infect Dis. 2009 Aug 15;200(4):528-36. doi: 10.1086/600385.

42.

Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women.

Hawn TR, Scholes D, Li SS, Wang H, Yang Y, Roberts PL, Stapleton AE, Janer M, Aderem A, Stamm WE, Zhao LP, Hooton TM.

PLoS One. 2009 Jun 22;4(6):e5990. doi: 10.1371/journal.pone.0005990.

43.

Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli.

Henderson JP, Crowley JR, Pinkner JS, Walker JN, Tsukayama P, Stamm WE, Hooton TM, Hultgren SJ.

PLoS Pathog. 2009 Feb;5(2):e1000305. doi: 10.1371/journal.ppat.1000305. Epub 2009 Feb 20.

44.

Results of survey on implementation of Infectious Diseases Society of America and Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.

Pope SD, Dellit TH, Owens RC, Hooton TM; Infectious Diseases Society of America; Society for Healthcare Epidemiology of America.

Infect Control Hosp Epidemiol. 2009 Jan;30(1):97-8. doi: 10.1086/592979. No abstract available.

PMID:
19046053
45.

Complicated urinary tract infections.

Lichtenberger P, Hooton TM.

Curr Infect Dis Rep. 2008 Nov;10(6):499-504.

PMID:
18945392
46.

Placebo found equivalent to amoxicillin for treatment of acute bronchitis in Nairobi, Kenya: a triple blind, randomised, equivalence trial.

Nduba VN, Mwachari CW, Magaret AS, Park DR, Kigo A, Hooton TM, Cohen CR.

Thorax. 2008 Nov;63(11):999-1005. doi: 10.1136/thx.2008.097311. Epub 2008 Jun 17.

PMID:
18559367
47.

Detection of intracellular bacterial communities in human urinary tract infection.

Rosen DA, Hooton TM, Stamm WE, Humphrey PA, Hultgren SJ.

PLoS Med. 2007 Dec;4(12):e329.

48.

Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women.

Gupta K, Hooton TM, Roberts PL, Stamm WE.

Arch Intern Med. 2007 Nov 12;167(20):2207-12.

PMID:
17998493
49.

Population-based epidemiologic analysis of acute pyelonephritis.

Czaja CA, Scholes D, Hooton TM, Stamm WE.

Clin Infect Dis. 2007 Aug 1;45(3):273-80. Epub 2007 Jun 19.

PMID:
17599303
50.

Differential stability and trade-off effects of pathoadaptive mutations in the Escherichia coli FimH adhesin.

Weissman SJ, Beskhlebnaya V, Chesnokova V, Chattopadhyay S, Stamm WE, Hooton TM, Sokurenko EV.

Infect Immun. 2007 Jul;75(7):3548-55. Epub 2007 May 14. Erratum in: Infect Immun. 2009 Apr;77(4):1720.

Supplemental Content

Loading ...
Support Center